Endocannabinoid
Resource Center
TOP ARTICLES
Could CBD Reduce COVID Lung Damage? A Protective Peptide May Be the Answer
New research shows that CBD appears to reduce the “cytokine storm” that damages the lungs and kills many patients with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is known to reduce inflammation and whose levels are dramatically reduced in the face of
Cannabis Users Need More Anesthesia During Surgery and Opioids in Recovery
Not only might cannabis users need more anesthesia during surgery than non-users, they may have increased pain afterwards and use higher doses of opioids while in the hospital, suggests first-of-its kind research being presented at the ANESTHESIOLOGY® 2020 annual meeting. Adding to the growing body of research that shows patients
Activation of Cannabinoid Receptor 2 Prevents Colitis-Associated Colon Cancer in Mice
Inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis are caused by unrestrained inflammation of the gastrointestinal tract. Patients with IBD are at a higher risk of developing colorectal cancer. In a recent study published in iScience by authors from the University of South Carolina, it was shown
Systematic Review and Meta-analysis: Cannabinoids in the Management of Acute Pain
A new systematic review and meta-analysis showed a small but significant reduction in subjective pain scores for cannabinoid treatment compared to placebo in patients experiencing acute pain. No increase in serious adverse events suggested the safety of using cannabinoids to treat acute pain, according to the study published in Cannabis
Free Webinar: The Endocannabinoid System: Therapeutic Impact of Hemp and Full-spectrum Cannabinoids.
Healthcare professionals often have a knowledge gap when it comes to navigating the nascent hemp industry and providing evidence-based counseling to their communities. This webinar, Endocannabinoid System: Therapeutic Impact of Hemp and Full-spectrum Cannabinoids with Alex Capano, PhD, NP, BSN, MSN will cover the therapeutic potential and current scientific evidence
FDA Issues Consumer Warnings Statements About Cannabidiol
In November 2019 FDA issued a strong set of warning statements about cannabidiol. The agency said that “based on the lack of scientific information supporting the safety of CBD in food, the FDA … cannot conclude that CBD is generally recognized as safe (GRAS) among qualified experts for its use
Cannabis for Post-traumatic Stress Disorder Therapy
A new study shows that cannabis may be helpful to address the effects of post-traumatic stress disorder (PTSD). According to health survey data collected by Statistics Canada from more than 24,000 Canadians, researchers from the BC Centre on Substance Use (BCCSU) and University of British Columbia (UBC) found that people
